Pipeline

At the heart of Charleston Laboratories lies our product pipeline. Designed with one purpose and packed with limitless promise, our focused pipeline is destined to change how the world treats acute pain by preventing or reducing the common side effects of nausea and vomiting, providing patients with proper pain relief while reducing the high risk of recovery setbacks.

Acute Pain Learn More
CL-108 (Hydrocodone / APAP & Promethazine) 7.5 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-108 (Hydrocodone / APAP & Promethazine) 5 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-108 (Hydrocodone / APAP & Promethazine) 10 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLOX-315 (Oxycodone HCI & Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLP-417 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLP-517 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Central Nervous System Learn More
CL-H1T (Sumatriptan & Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-H2T (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Respiratory Learn More
CLR-AT-313 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLR-AT-413 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLR-AT-513 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Abuse-Deterrent Formulations Learn More
Abuse-Deterrence (ABUSE-DETERRENT FORMULATIONS) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Academic Collaborations Learn More
STANFORD PROJECT (STANFORD UNIVERSITY COLLABORATION) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide